JPS6328427A - Humidity conditioning agent - Google Patents
Humidity conditioning agentInfo
- Publication number
- JPS6328427A JPS6328427A JP17079286A JP17079286A JPS6328427A JP S6328427 A JPS6328427 A JP S6328427A JP 17079286 A JP17079286 A JP 17079286A JP 17079286 A JP17079286 A JP 17079286A JP S6328427 A JPS6328427 A JP S6328427A
- Authority
- JP
- Japan
- Prior art keywords
- humidity
- moisture
- conditioning agent
- relative humidity
- potassium carbonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Drying Of Gases (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
【発明の詳細な説明】
技術分野
本発明は調湿剤に関する。更に詳しくは、本発明は密閉
容器内の水分量又は湿度を吸湿あるいは放湿作用により
特定の範囲内に調節して維持することができ、しかも吸
収水分により潮解することのない調湿剤に関する。DETAILED DESCRIPTION OF THE INVENTION TECHNICAL FIELD The present invention relates to humectants. More specifically, the present invention relates to a humidity conditioner that can adjust and maintain the amount of moisture or humidity in a closed container within a specific range by moisture absorption or moisture release, and which does not deliquesce due to absorbed moisture.
先行技術
薬剤の品質保持のための防湿剤としてシリカゲル、アル
ミナゲル及びその他の、例えば塩化カルシウムのような
無機塩類より成る乾燥剤が屡々使用されて来た。しかし
ながら、これら乾燥剤は、その特性の大半が吸湿作用を
示し、乾燥剤の吸湿平衡量に達するまで水分を吸収し続
け、乾燥剤の量が容器容量と薬剤特性との関係から過大
である場合に容器内を過度に乾燥した状態にして了うこ
とかある。このような状況下に該容器中に例えば薬剤を
充てんしたカプセルを入れておいた場合に、薬剤が放湿
する水分以外にカプセル自体の水分をも吸収して了い、
カプセル割れを生じさせる恐れがある。また例えば塩化
カルシウムのような無機塩を使用した乾燥剤は潮解性を
有し、それ自体の吸収水分のために液状化し、乾燥剤と
して使用するに当シ作業上不適となる場合がある。Desiccants consisting of silica gel, alumina gel and other inorganic salts, such as calcium chloride, have often been used as desiccant agents for the preservation of prior art pharmaceuticals. However, most of these desiccant properties exhibit hygroscopic action, and they continue to absorb moisture until the moisture absorption equilibrium amount of the desiccant is reached, and if the amount of desiccant is excessive due to the relationship between the container capacity and the drug properties. This can sometimes leave the inside of the container in an excessively dry state. If, for example, a capsule filled with a drug is placed in the container under such circumstances, in addition to the moisture released by the drug, the capsule itself will also absorb moisture.
May cause capsule cracking. Furthermore, desiccant agents using inorganic salts such as calcium chloride have deliquescent properties and liquefy due to their own absorption of moisture, making them unsuitable for use as desiccant agents.
一般的に薬剤の品質保持の見地から好ましいとてれてい
る湿度は、相対湿度30〜40%である。Generally, the preferred humidity from the viewpoint of maintaining the quality of drugs is 30 to 40% relative humidity.
このような好ましい湿度を維持する調湿剤が当業界にお
いて望まれている。There is a need in the art for a humidity control agent that maintains such a desirable humidity level.
発明の要約
本発明は上記の目的を達成するための調湿剤を提供する
ものである。SUMMARY OF THE INVENTION The present invention provides a humectant to achieve the above objects.
本発明の調湿剤は(4)無水ケイ酸と、[F])目的湿
度に応じて任意に定めた特定の塩との混合物である。The humidity conditioner of the present invention is a mixture of (4) silicic anhydride and [F]) a specific salt arbitrarily determined depending on the target humidity.
本発明の調湿剤はそれが使用される環境(一定容量をも
つ密閉容器)が所望の湿度よりも高い場合には吸湿作用
によりボ光を吸収して容器内を所望の範囲内の湿度に低
下させ、あるいはまたこれと逆に容器内の湿度が所望の
湿度よりも低過ぎる場合には調湿剤自体が含有する水分
を放出して容器内を所望の湿度に高める作用を有する。When the humidity conditioner of the present invention is used in an environment (a sealed container with a certain capacity) that is higher than the desired humidity, it absorbs sunlight through its hygroscopic action and brings the humidity inside the container within the desired range. Or, conversely, if the humidity inside the container is too low than the desired humidity, the humidity conditioner itself has the effect of releasing the moisture contained therein and increasing the humidity inside the container to the desired humidity.
本発明の調湿剤は従来の塩化カルシウム乾燥剤のように
潮解性を有しないので、゛べたつく恐れがなく、また実
際の作業に当り、長時間放置しておいても十分に初期の
調湿能力を維持することができる。The humidity control agent of the present invention does not have deliquescent properties like conventional calcium chloride drying agents, so there is no risk of it becoming sticky, and in actual work, even if left for a long time, the initial humidity control is sufficient. ability can be maintained.
本発明の調湿剤に使用する無水ケイ酸としては慣用の乾
燥剤のシリカゲル及び軽質無水ケイ酸がある。サイロイ
ド(商標)のような軽質無水ケイ酸塩が特に好ましい。The silicic anhydride used in the humidity conditioner of the present invention includes silica gel and light silicic anhydride, which are conventional desiccants. Particularly preferred are light anhydrous silicates such as Cyroid™.
本発明の調湿剤に使用するのに好ましい塩は、重クロム
酸ナトリウム、硝酸マグネシウム、炭酸カリウム、塩化
マグネシウム、酢酸カリウム及び塩化カルシウムより成
る群から選択されるものである。これらの塩は無水ケイ
酸と混合した場合に、それぞれ異なる水準の相対湿度を
示すので所望の湿度水準を考慮して選択すべきである。Preferred salts for use in the humidifier of the invention are selected from the group consisting of sodium dichromate, magnesium nitrate, potassium carbonate, magnesium chloride, potassium acetate and calcium chloride. These salts exhibit different levels of relative humidity when mixed with silicic anhydride and should be selected with the desired humidity level in mind.
第1図に本発明の調湿剤における各種の塩と、得られる
相対湿度との関係を示す。この湿度水準は調湿剤の配合
比によって多少上下するけれども、塩の種類と得られる
相対湿度との大体の関係を知ることができる。それ故、
この図に基づいて、配合すべき塩を選択することができ
る。例えば一般的に最も好ましい湿度とされる相対湿度
30〜40チを得るためKは塩として炭酸カリウムを使
用することが最も望ましい。FIG. 1 shows the relationship between various salts in the humidity conditioner of the present invention and the resulting relative humidity. Although this humidity level varies somewhat depending on the blending ratio of the humidity conditioner, it is possible to know the general relationship between the type of salt and the relative humidity obtained. Therefore,
Based on this figure, the salt to be blended can be selected. For example, in order to obtain a relative humidity of 30 to 40 degrees, which is generally considered the most preferable humidity, it is most desirable to use potassium carbonate as the salt.
本発明の調湿剤の使用量は容器容量と調湿剤による一定
容器内の吸収又は放出されるべき水分の量とに関係する
。すなわち、調湿剤使用前の湿度と所望の定常湿度との
差、及び薬剤の入った密封容器又は包装の容量とを考慮
して定めるべきである。計算量よりも多量に使用しても
差支えないけれど経済的に、及び作業上好ましくない。The amount of moisture conditioning agent of the present invention used is related to the container volume and the amount of moisture to be absorbed or released within a given container by the moisture conditioning agent. That is, it should be determined by taking into consideration the difference between the humidity before using the humidity conditioner and the desired steady-state humidity, and the capacity of the sealed container or package containing the medicine. Although there is no problem in using a larger amount than the amount of calculation, it is not preferable from an economical and operational point of view.
無水ケイ酸と塩との配合比は厳密に臨界的ではないが無
水ケイ酸対塩の1i量比10:1ないし1:2の範囲が
好ましい。Although the blending ratio of silicic anhydride and salt is not strictly critical, the ratio of silicic anhydride to salt is preferably in the range of 10:1 to 1:2.
実施例1
市販のサイロイド(商標)粉末1.OFと、市販の工業
用炭酸カリウム粉末0.12とを混合し、これを水分透
過性の極めて高いプラスチックフィルム製、又はこれら
をラミネートした積層体フィルム製の袋に詰めた。Example 1 Commercially available Cyroid (trademark) powder 1. OF and 0.12% of a commercially available industrial potassium carbonate powder were mixed and packed into a bag made of a plastic film with extremely high moisture permeability or a laminated film made by laminating them.
一方NaC2飽和水溶液(相対湿度75.1%)200
ccを入れた容f2tのデシケータに容量100 cc
の広口ガラスピンを開放状態にして入れ、デシケータを
密閉し、室温において5時間放置し、湿度計によりガラ
スビン内の相対湿度とデシケータ内の相対湿度が共に7
5チであることを確認した。次いで該ガラスビンを取シ
出し、上記袋詰めしたティロイド(商標)と炭酸カリウ
ムとの混合物を入れ、それと同時に素早く密栓し、経時
的に容器内の湿度を測定した。結果を第1図において曲
線−0−0−Kより示す。第1図に示されるように約5
0分後に相対湿度30〜4oチの範囲に到達し、約3時
間後において相対湿度約33チの定常値を保った。On the other hand, NaC2 saturated aqueous solution (relative humidity 75.1%) 200
Capacity 100 cc in a desiccator with capacity f2t containing cc
Put the wide-mouthed glass pin in the open state, seal the desiccator, and leave it at room temperature for 5 hours.The relative humidity inside the glass bottle and the relative humidity inside the desiccator are both 7 as measured by a hygrometer.
I confirmed that it was 5. Next, the glass bottle was taken out, and the bagged mixture of Tyroid (trademark) and potassium carbonate was added thereto, and at the same time, the bottle was quickly sealed, and the humidity inside the bottle was measured over time. The results are shown in FIG. 1 by curve -0-0-K. Approximately 5 as shown in Figure 1
After 0 minutes, the relative humidity reached a range of 30 to 4 degrees, and after about 3 hours, the relative humidity remained at a steady value of about 33 degrees.
実施例2
炭酸カリウムの代シに1同量の重クロム酸ナトリウムを
使用した点を除いて実施例1の手順を〈)返した。結果
を第1図の曲線−Δ−ムーLυ示す。Example 2 The procedure of Example 1 was repeated except that an equal amount of sodium dichromate was used in place of potassium carbonate. The results are shown in the curve −Δ−mu Lυ in FIG.
約1時間後において相対湿度の定常値約45チが得られ
た。After about 1 hour, a steady value of about 45 degrees of relative humidity was obtained.
実施例5
炭酸カリウムの代#)K1同量の硝酸マグネシウムを使
用した点を除いて実施例1の手順をく)返した。結果を
81図の曲線−×−×−にょシ示す。約60分後におい
て相対湿度の定常値約42チが得られた0
実施例4
炭酸カリウムの代シに1同量の塩化マグネシウムを使用
した点を除いて実施例1の手順を〈シ返した。結果を第
1図の曲線−■−■−により示す。約1時間半後におい
て相対湿度の定常値約28チが得られた。Example 5 The procedure of Example 1 was repeated except that the same amount of magnesium nitrate was used instead of potassium carbonate. The results are shown in the curve -x-x- in Figure 81. After about 60 minutes, a steady value of about 42 degrees of relative humidity was obtained.Example 4 The procedure of Example 1 was repeated except that the same amount of magnesium chloride was used in place of potassium carbonate. . The results are shown by curves -■-■- in FIG. After about one and a half hours, a steady value of about 28 degrees of relative humidity was obtained.
実施例5
炭酸カリウムの代りに、同量の酢酸カリウムをにおいて
相対湿度の定常値約20チが得られた。 一実施例6
炭酸カリウムの代シに、同量の塩化カルシウムを使用し
た点を除いて実施例1の手虜をくシ返した。結果を第1
図の曲線−一−ム−により示す。約2時間後において相
対湿度の定常値約20%が得られた0
実施例7
サイロイド(商標)及び炭酸カリウムの使用量を下表に
示すように変動させて実施例1の手順をくり返した。Example 5 Using the same amount of potassium acetate instead of potassium carbonate, a constant value of relative humidity of about 20 degrees was obtained. Example 6 The procedure of Example 1 was repeated, except that the same amount of calcium chloride was used in place of potassium carbonate. Results first
This is shown by the curve in the figure. After about 2 hours, a steady-state value of about 20% relative humidity was obtained.0 Example 7 The procedure of Example 1 was repeated, varying the amounts of Thyroid™ and potassium carbonate used as shown in the table below.
炭酸カリウム サイロイド 配合比 曲線記号0
1 0:1 00.111:10
口
C212:10 Δ
o、s 1s:1o xto 11
:1厘
16 C82:1 ^2.0
0 2 : 0 ・結果を第2図に
示す。第2図は配合比を種々変動させても結果的にすべ
てが定常湿度2?〜39チの範囲内に納まることを示す
。Potassium carbonate thyroid blending ratio curve symbol 0
1 0:1 00.111:10
Mouth C212:10 Δ o,s 1s:1o xto 11
:1 rin16 C82:1 ^2.0
0 2 : 0 - The results are shown in Figure 2. Figure 2 shows that even if the blending ratio is varied, the result is that the constant humidity is 2? This indicates that it falls within the range of ~39 cm.
しかしながら、サイロイドのみの場合には過少湿度から
の調湿が不可能であること、及び炭酸カリウムのみの場
合には潮解現象が生じ、かつ過少湿度からの調湿゛が不
可能であることに注意すべきである。However, it should be noted that if only thyroid is used, it is impossible to control humidity from too low a humidity, and if only potassium carbonate is used, a deliquescence phenomenon occurs and it is impossible to control humidity from too low a humidity. Should.
実施例8
予めNaCt飽和水溶液(相対湿度75.1チ)櫂に1
〜7時間放置した炭酸カリウムの5試料を用意し、それ
ぞれについて実施例1の記載と同じ手順の実験を行い、
経時的に相対湿度を測定した。ただし実施例IKおける
NaCt飽和水溶液(相対湿度75.1% ) 200
ccの代シに塩化リチウム飽和水溶液(相対湿度1t
5チ) 200 ccを使用した。結果を第3図に示す
。ガラスピン内の初期相対湿度は約11チであった。こ
れに対し、調湿剤の水分は相対湿度75.1%のNaC
1槽で吸湿させた調湿剤の1時間吸湿品と7時間吸湿品
との間Kかなシ大きな差があるにも拘わらず調湿剤から
の放湿によりi節された相対湿反の定常値はほぼ所望範
囲の26〜39%の間に納まった。このことは調湿剤の
含有水分はその調湿能力に大きな影響を及ぼさないこと
を意味する。またこの結果より、相対湿度11チ程度の
容器内湿度から、30〜40チに相対湿度を調節するに
はNaC1槽(相対湿度75,1チ)で3〜7時間吸湿
させておけは、より効果的であることがわかる。Example 8 NaCt saturated aqueous solution (relative humidity 75.1 degrees) was added to the paddle in advance.
Five samples of potassium carbonate that had been left for ~7 hours were prepared and each was subjected to an experiment using the same procedure as described in Example 1.
Relative humidity was measured over time. However, the NaCt saturated aqueous solution (relative humidity 75.1%) in Example IK was 200
Lithium chloride saturated aqueous solution (relative humidity 1 t) in place of cc
5) 200 cc was used. The results are shown in Figure 3. The initial relative humidity within the glass pin was approximately 11 degrees. On the other hand, the moisture in the humidity conditioner is NaC with a relative humidity of 75.1%.
Although there is a large difference in K between the 1-hour moisture-absorbing product and the 7-hour moisture-absorbing product of the humidity conditioner that was absorbed in one tank, the relative humidity is constant due to the release of moisture from the humidity conditioner. The values were approximately within the desired range of 26-39%. This means that the moisture content of the humidity conditioner does not significantly affect its humidity conditioning ability. In addition, from this result, in order to adjust the relative humidity from the relative humidity inside the container of about 11 degrees to 30 to 40 degrees, it is better to let it absorb moisture for 3 to 7 hours in a NaC tank (relative humidity 75.1 degrees). It turns out to be effective.
第1図は本発明の各種調湿剤を使用することによって得
られる相対湿度と、使用時間との関係を一定の容器内に
おける過大な湿度から出発した場合について示すグラフ
図である0
第2図は本発明の炭酸カリウムと無水ケイ酸とより成る
調湿剤における炭酸カリウムと無水ケイ酸゛との重量比
と、一定の容器内において得られる定常相対湿度との関
係を示すグラフ図である0第3図は本発明の炭酸カリウ
ムと無水ケイ酸とより成る調湿剤における、調湿剤の初
期含水量と、得られる定常相対湿度との関係を一定容器
内における過少湿度から出発した場合について示すグラ
フ図である。Figure 1 is a graph showing the relationship between the relative humidity obtained by using various humidity conditioners of the present invention and the usage time when starting from excessive humidity in a certain container.0 Figure 2 0 is a graph showing the relationship between the weight ratio of potassium carbonate and silicic anhydride in the humidity conditioner made of potassium carbonate and silicic anhydride of the present invention, and the steady relative humidity obtained in a certain container. Figure 3 shows the relationship between the initial moisture content of the humidity conditioner and the resulting steady-state relative humidity of the humidity conditioner made of potassium carbonate and silicic anhydride according to the present invention, starting from an insufficient humidity in a constant container. FIG.
Claims (1)
、硝酸マグネシウム、炭酸カリウム、塩化マグネシウム
、酢酸カリウム及び塩化カルシウムより成る群から選択
される塩との混合物より成ることを特徴とする調湿剤。 2、無水ケイ酸と塩との重量比が、10:1ないし1:
2である特許請求の範囲第1項記載の調湿剤。[Claims] 1. From a mixture of (A) silicic anhydride and (B) a salt selected from the group consisting of sodium dichromate, magnesium nitrate, potassium carbonate, magnesium chloride, potassium acetate, and calcium chloride. A humidifying agent characterized by: 2. The weight ratio of silicic anhydride and salt is 10:1 to 1:
2. The humidity conditioner according to claim 1, which is
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61170792A JPH07106295B2 (en) | 1986-07-22 | 1986-07-22 | Humidifier |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61170792A JPH07106295B2 (en) | 1986-07-22 | 1986-07-22 | Humidifier |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6328427A true JPS6328427A (en) | 1988-02-06 |
JPH07106295B2 JPH07106295B2 (en) | 1995-11-15 |
Family
ID=15911441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61170792A Expired - Fee Related JPH07106295B2 (en) | 1986-07-22 | 1986-07-22 | Humidifier |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07106295B2 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007223972A (en) * | 2006-02-24 | 2007-09-06 | Shionogi & Co Ltd | Vitamin b12-containing compound |
AU2005283422B2 (en) * | 2004-09-17 | 2010-05-13 | Eisai R & D Management Co., Ltd. | Medicinal composition |
US7994159B2 (en) | 2003-03-10 | 2011-08-09 | Eisai R&D Management Co., Ltd. | c-Kit kinase inhibitor |
US10407393B2 (en) | 2014-08-28 | 2019-09-10 | Eisai R&D Management Co., Ltd. | High-purity quinoline derivative and method for manufacturing same |
US10517861B2 (en) | 2013-05-14 | 2019-12-31 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds |
US11090386B2 (en) | 2015-02-25 | 2021-08-17 | Eisai R&D Management Co., Ltd. | Method for suppressing bitterness of quinoline derivative |
US11369623B2 (en) | 2015-06-16 | 2022-06-28 | Prism Pharma Co., Ltd. | Anticancer combination of a CBP/catenin inhibitor and an immune checkpoint inhibitor |
US11547705B2 (en) | 2015-03-04 | 2023-01-10 | Merck Sharp & Dohme Llc | Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancer |
US11598776B2 (en) | 2011-06-03 | 2023-03-07 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds |
US12220398B2 (en) | 2015-08-20 | 2025-02-11 | Eisai R&D Management Co., Ltd. | Tumor therapeutic agent |
US12226409B2 (en) | 2017-05-16 | 2025-02-18 | Eisai R&D Management Co., Ltd. | Treatment of hepatocellular carcinoma |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52126938A (en) * | 1976-04-16 | 1977-10-25 | Tadaichi Ushida | Moisture adjustment seat |
JPS5631439A (en) * | 1979-08-18 | 1981-03-30 | Tokuyama Soda Co Ltd | Desiccant |
JPS5715840A (en) * | 1980-07-01 | 1982-01-27 | Mitsubishi Electric Corp | Hygroscopic agent |
-
1986
- 1986-07-22 JP JP61170792A patent/JPH07106295B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52126938A (en) * | 1976-04-16 | 1977-10-25 | Tadaichi Ushida | Moisture adjustment seat |
JPS5631439A (en) * | 1979-08-18 | 1981-03-30 | Tokuyama Soda Co Ltd | Desiccant |
JPS5715840A (en) * | 1980-07-01 | 1982-01-27 | Mitsubishi Electric Corp | Hygroscopic agent |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7994159B2 (en) | 2003-03-10 | 2011-08-09 | Eisai R&D Management Co., Ltd. | c-Kit kinase inhibitor |
AU2005283422B2 (en) * | 2004-09-17 | 2010-05-13 | Eisai R & D Management Co., Ltd. | Medicinal composition |
JP4834553B2 (en) * | 2004-09-17 | 2011-12-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Pharmaceutical composition |
US8969379B2 (en) | 2004-09-17 | 2015-03-03 | Eisai R&D Management Co., Ltd. | Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide |
AU2005283422C1 (en) * | 2004-09-17 | 2017-02-02 | Eisai R & D Management Co., Ltd. | Medicinal composition |
JP2007223972A (en) * | 2006-02-24 | 2007-09-06 | Shionogi & Co Ltd | Vitamin b12-containing compound |
US11598776B2 (en) | 2011-06-03 | 2023-03-07 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds |
US10517861B2 (en) | 2013-05-14 | 2019-12-31 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds |
US10822307B2 (en) | 2014-08-28 | 2020-11-03 | Eisai R&D Management Co., Ltd. | High-purity quinoline derivative and method for manufacturing same |
US11186547B2 (en) | 2014-08-28 | 2021-11-30 | Eisai R&D Management Co., Ltd. | High-purity quinoline derivative and method for manufacturing same |
US10407393B2 (en) | 2014-08-28 | 2019-09-10 | Eisai R&D Management Co., Ltd. | High-purity quinoline derivative and method for manufacturing same |
US11090386B2 (en) | 2015-02-25 | 2021-08-17 | Eisai R&D Management Co., Ltd. | Method for suppressing bitterness of quinoline derivative |
US11547705B2 (en) | 2015-03-04 | 2023-01-10 | Merck Sharp & Dohme Llc | Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancer |
US12083112B2 (en) | 2015-03-04 | 2024-09-10 | Eisai R&D Management Co., Ltd. | Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer |
US11369623B2 (en) | 2015-06-16 | 2022-06-28 | Prism Pharma Co., Ltd. | Anticancer combination of a CBP/catenin inhibitor and an immune checkpoint inhibitor |
US12220398B2 (en) | 2015-08-20 | 2025-02-11 | Eisai R&D Management Co., Ltd. | Tumor therapeutic agent |
US12226409B2 (en) | 2017-05-16 | 2025-02-18 | Eisai R&D Management Co., Ltd. | Treatment of hepatocellular carcinoma |
Also Published As
Publication number | Publication date |
---|---|
JPH07106295B2 (en) | 1995-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2401451C2 (en) | Device for controlling relative moisture | |
US8029842B2 (en) | Low water activity oxygen scavenger and methods of using | |
US6667273B1 (en) | Composition for absorbing oxygen in an oxygen/carbon dioxide environment | |
JPS6328427A (en) | Humidity conditioning agent | |
US6235219B1 (en) | Compositions useful as desiccants and methods relating thereto | |
RU2640540C2 (en) | Composition for regulating humidity of environment, method of its manufacture and its use for regulating humidity of environment | |
JPS6028531B2 (en) | dehumidifier | |
WO2008040841A1 (en) | A desiccant system for the regulation of humidity in inhalation powders | |
JPS58219919A (en) | Drying composition and package | |
BRPI1014873B1 (en) | Long-term storage method of viable lyophilized lactic acid probiotic bacteria, and, probiotic product | |
JPS58177137A (en) | Carbon dioxide gas absorbent | |
JPS626848B2 (en) | ||
JPH0220270A (en) | Releasing agent of carbon dioxide gas | |
JPH0321148B2 (en) | ||
JPS61216715A (en) | Drying composition and package | |
JPS6054094B2 (en) | solid desiccant | |
JP3254024B2 (en) | Dehumidifier | |
JP3169285B2 (en) | Oxygen scavenger | |
JPS62117614A (en) | Drying agent | |
JPS60143819A (en) | Dehumidifying agent | |
JPS62112553A (en) | Dehymidifying deodorant | |
JPS61141916A (en) | Desiccant composition and molded article | |
JPH02284647A (en) | Disoxidant | |
JPS63287533A (en) | Dehumidifying agent | |
JPH04244229A (en) | Oxygen absorbent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |